ACE2 and COVID-19: ACE2 (rs4646116) polymorphism did not exhibit a statistically significant effect on COVID-19 risk, although the carriers of ACE2*TC + CC genotype were at slightly increased risk in comparison to individuals with ACE2*TT genotype (OR = 1.79, 95%CI = 0.89–3.57, p = 0.100).